loader image
Wednesday, October 8, 2025
80.3 F
McAllen
- Advertisement -

DHR Welcomes Maternal-Fetal Medicine Physician

Translate to Spanish or other 102 languages!

 Dr. Cherie Johnson provides specialized patient care for women with complex, high-risk pregnancies.
Dr. Cherie Johnson provides specialized patient care for women with complex, high-risk pregnancies.

Revolutionizes Care for High Risk Pregnancies in the Valley

- Advertisement -

Mega Doctor News

Edinburg, TX — Doctors Hospital at Renaissance is proud to welcome Dr. Cherie Jeanne Johnson, a board certified Maternal-Fetal Medicine physician who specializes in the diagnosis, treatment, and ongoing care for expectant mothers and their unborn babies who are at a high risk for special health problems.

Maternal-Fetal Medicine (MFM) — first recognized by the American Board of Obstetrics and Gynecology in 1973 — grew from a need to care for increasingly complicated pregnancies and from new technologies that provided greater opportunity to evaluate and treat problems involving the fetus. MFM specialists are highly trained obstetrician/gynecologists with advanced expertise in obstetric, medical, and surgical complications of pregnancy and their effects on the mother and fetus. MFM specialists, such as Dr. Johnson, provide care for women with preexisting health problems, conditions that arise during pregnancy (ex. gestational diabetes, hypertension, and placental bleeding), and women who have complications relating to the fetus itself.

- Advertisement -

Dr. Johnson’s goal as a Maternal-Fetal Medicine specialist is to care for normal pregnancies as well as those who are at a high-risk for health problems. She monitors and evaluates women throughout their pregnancies and delivers at the Women’s Hospital at Renaissance. While some women need only a single consultation before or during pregnancy to help them prepare for delivery, others may require ongoing MFM specialist care, such as monitoring their condition through regular prenatal visits, performing fetal assessments with ultrasound and/or invasive procedures, and assistance during the delivery.

Pregnancies with a greater chance of complications are called high-risk pregnancies. Dr. Cherie Johnson plays a key role in enhancing safety for her patients with high-risk pregnancies. In complex cases that require multidisciplinary care, MFM specialists have the greatest understanding of maternal and fetal physiology, can coordinate care with other healthcare providers, and can provide information to other specialists about the risks and benefits of interventions, medications, and diagnostic testing during pregnancy. The following factors may increase the risk of complications during pregnancy:

Mother is very young or older than 35

Mother is overweight or underweight

- Advertisement -

Problems with a previous pregnancy

Multiple gestation (pregnancy with twins or other multiples)

In addition to the factors above, the most common medical illnesses treated by an MFM specialist include hypertension, preeclampsia, diabetes, autoimmune or infectious diseases, seizure disorders, and a known or suspected fetal anomaly, such as abnormal fetal growth. MFM specialists provide care for women who are at an increased risk of preterm birth, women with cervical insufficiency, and women with placental problems such as bleeding from premature separation (placental abruption). Mothers with a family history of cardiac disease, renal disease, gastrointestinal disease, and cystic fibrosis may also benefit from seeing a Maternal-Fetal Medicine specialist.

Dr. Johnson is specially trained in diagnostic ultrasound, which plays an important role in screening for fetal chromosome abnormalities and birth defects. Technological advances, including new diagnostic tools and treatments, have optimized care and pregnancy outcomes. For example, obstetric ultrasonography has revolutionized pregnancy care by providing a better view of the womb and allowing for the identification of previously unknown problems in the fetus.

From pre-conception counseling through delivery and recovery, Dr. Cherie Johnson provides a full range of gynecologic reproductive healthcare services in a caring and considerate manner for women in the Rio Grande Valley. Procedures and medical services requiring hospitalization are readily available just blocks away at the Women’s Hospital at Renaissance. Moreover, through her association with Doctors Hospital at Renaissance, Dr. Johnson has access to a network of highly skilled neonatologists, obstetrician/gynecologists, geneticists, psychotherapists, nutritionist and others who are readily available for consultation and treatment if needed. Together, they provide a comprehensive range of women’s healthcare services.

Dr. Johnson received her bachelor’s degree from the University of California and her medical degree from Thomas Jefferson University. She received residency training in obstetrics and gynecology at the Medical Center of Delaware and completed a fellowship in maternal-fetal medicine at the University of California and Long Beach Memorial Medical Center Women’s Hospital.  MDN

 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Unidos Contra la Diabetes to Host 2025 Mini-Symposium and Annual Dia-Beat-IT Health Fair, Nov. 5th

Unidos Contra la Diabetes (UCD) has announced that its 2025 Mini-Symposium and Annual Dia-Beat-IT Health Fair is less than a month away. Moises Arjona Jr., MS, CHWI, Collective Impact Director for UCD, reminded community partners and stakeholders of the upcoming event, encouraging participation and support.

DHR Health Breast Cancer Symposium, Oct. 11th 

To support providers in the community, the DHR Health Continuing Medical Education Department will host the Breast Cancer Symposium on Saturday, October 11, at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado.

DHR Health Introduces Advanced PSMA-PET Imaging with Illuccix® for Prostate Cancer Care

To support early and accurate detection, DHR Health now offers Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection), a prostate-specific membrane antigen (PSMA) targeted positron emission tomography (PET) imaging tracer for the detection of prostate cancer.

TMA Supports Guidelines Recommending Younger Breast Cancer Screening Age

Women should begin routine annual mammography screenings at age 40, according to guidelines by the American College of Radiology and Society of Breast Imaging (ACR/SBI). Breast cancer screening guidelines vary on the initiation age for mammograms (40 versus 45 versus 50 years of age) and screening frequency (annual versus biennial).
- Advertisement -
×